Priaxon AG - Product Pipeline Review - 2015

  • ID: 3440686
  • Company Profile
  • 38 pages
  • Global Markets Direct
1 of 4
Priaxon AG - Product Pipeline Review - 2015

Summary

The report ‘Priaxon AG - Product Pipeline Review - 2015’, provides an overview of the Priaxon AG’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Priaxon AG’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

The report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles/records featured in the report undergoes periodic updates following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Priaxon AG including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Priaxon AG’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Priaxon AG’s pipeline products

Reasons to buy

- Evaluate Priaxon AG’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Priaxon AG in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Priaxon AG’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Priaxon AG and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Priaxon AG
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Priaxon AG and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Priaxon AG Snapshot

Priaxon AG Overview

Key Information

Key Facts

Priaxon AG - Research and Development Overview

Key Therapeutic Areas

Priaxon AG - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Priaxon AG - Pipeline Products Glance

Priaxon AG - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Discovery Products/Combination Treatment Modalities

Priaxon AG - Drug Profiles

347-PXN-0209

Product Description

Mechanism of Action

R&D Progress

449-PXN-4017

Product Description

Mechanism of Action

R&D Progress

509-PXN-0001

Product Description

Mechanism of Action

R&D Progress

517-PXN

Product Description

Mechanism of Action

R&D Progress

PXN-523

Product Description

Mechanism of Action

R&D Progress

PXN-527

Product Description

Mechanism of Action

R&D Progress

PXN-561

Product Description

Mechanism of Action

R&D Progress

PXN-727

Product Description

Mechanism of Action

R&D Progress

PXN-822

Product Description

Mechanism of Action

R&D Progress

300-PXN-0040

Product Description

Mechanism of Action

R&D Progress

333-PXN-0055

Product Description

Mechanism of Action

R&D Progress

489-PXN

Product Description

Mechanism of Action

R&D Progress

490-PXN

Product Description

Mechanism of Action

R&D Progress

Small Molecule to Inhibit PAK-1 for Cancer

Product Description

Mechanism of Action

R&D Progress

Small Molecules to Agonize Orexin Receptor for Pain

Product Description

Mechanism of Action

R&D Progress

Priaxon AG - Pipeline Analysis

Priaxon AG - Pipeline Products by Target

Priaxon AG - Pipeline Products by Route of Administration

Priaxon AG - Pipeline Products by Molecule Type

Priaxon AG - Pipeline Products by Mechanism of Action

Priaxon AG - Recent Pipeline Updates

Priaxon AG - Dormant Projects

Priaxon AG - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Priaxon AG, Key Information

Priaxon AG, Key Facts

Priaxon AG - Pipeline by Indication, 2015

Priaxon AG - Pipeline by Stage of Development, 2015

Priaxon AG - Monotherapy Products in Pipeline, 2015

Priaxon AG - Partnered Products in Pipeline, 2015

Priaxon AG - Partnered Products/ Combination Treatment Modalities, 2015

Priaxon AG - Preclinical, 2015

Priaxon AG - Discovery, 2015

Priaxon AG - Pipeline by Target, 2015

Priaxon AG - Pipeline by Route of Administration, 2015

Priaxon AG - Pipeline by Molecule Type, 2015

Priaxon AG - Pipeline Products by Mechanism of Action, 2015

Priaxon AG - Recent Pipeline Updates, 2015

Priaxon AG - Dormant Developmental Projects,2015

List of Figures

Priaxon AG - Pipeline by Top 10 Indication, 2015

Priaxon AG - Pipeline by Stage of Development, 2015

Priaxon AG - Monotherapy Products in Pipeline, 2015

Priaxon AG - Pipeline by Top 10 Target, 2015

Priaxon AG - Pipeline by Top 10 Route of Administration, 2015

Priaxon AG - Pipeline by Top 10 Molecule Type, 2015

Priaxon AG - Pipeline Products by Top 10 Mechanism of Action, 2015
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll